Correlation Between Context Therapeutics and Terns Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Context Therapeutics and Terns Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Context Therapeutics and Terns Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Context Therapeutics and Terns Pharmaceuticals, you can compare the effects of market volatilities on Context Therapeutics and Terns Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Context Therapeutics with a short position of Terns Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Context Therapeutics and Terns Pharmaceuticals.

Diversification Opportunities for Context Therapeutics and Terns Pharmaceuticals

0.91

Correlation Coefficient

Context Therapeutics  Terns Pharmaceuticals

Almost no diversification

The 3 months correlation between Context and Terns is 0.91. Overlapping area represents the amount of risk that can be diversified away by holding Context Therapeutics and Terns Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Terns Pharmaceuticals and Context Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Context Therapeutics are associated (or correlated) with Terns Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Terns Pharmaceuticals has no effect on the direction of Context Therapeutics i.e., Context Therapeutics and Terns Pharmaceuticals go up and down completely randomly.

Pair Corralation between Context Therapeutics and Terns Pharmaceuticals

Given the investment horizon of 90 days Context Therapeutics is expected to under-perform the Terns Pharmaceuticals. In addition to that, Context Therapeutics is 1.11 times more volatile than Terns Pharmaceuticals. It trades about -0.13 of its total potential returns per unit of risk. Terns Pharmaceuticals is currently generating about -0.11 per unit of volatility. If you would invest  781.00  in Terns Pharmaceuticals on December 5, 2024 and sell it today you would lose (418.00) from holding Terns Pharmaceuticals or give up 53.52% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Strong
Accuracy	100.0%
Values	Daily Returns

Context Therapeutics  vs.  Terns Pharmaceuticals

Context Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Context Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Terns Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Terns Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Context Therapeutics and Terns Pharmaceuticals

The main advantage of trading using opposite Context Therapeutics and Terns Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Context Therapeutics position performs unexpectedly, Terns Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Terns Pharmaceuticals will offset losses from the drop in Terns Pharmaceuticals' long position.

The idea behind Context Therapeutics and Terns Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.